IntrinsiQ Tendler Promotes Aversano for Top Job

In Canada, pharma market research firm IntrinsiQ Tendler has promoted Anthony Aversano to the post of President, with responsibility for day-to-day operations.

IntrinsiQ Tendler provides the Canadian pharma industry with custom market research and strategic marketing insight across the entire drug lifecycle. The firm also runs the TendlerView Oncology omnibus panel.

Its parent company IntinsiQ provides medical oncology clinical information systems through its IntelliDose tool, which captures treatment decisions and details from more than 750 oncologists and nearly 20,000 patients.

Aversano joined the firm as SVP in 2007 after a 20-year career in the pharmaceutical industry. During his time with the firm, he has played a key role in developing IntrinsiQ Tendler's research offerings. Prior to this, he held senior sales and market research positions at Pfizer Canada. He began his career in clinical research.

In his new role, Aversano replaces departing agency founder Sylvie Tendler, and will report to IntrinsiQ President Jeff Forringer.

'Anthony's vision and experience will continue to guide the firm's offerings and growth, and make significant contributions to our company's deep collective insights,' states Forringer.

Web sites: www.intrinsiqtendler.com and www.intrinsiq.com .